Literature DB >> 28566182

NUDT15 p.R139C variant is common and strongly associated with azathioprine-induced early leukopenia and severe alopecia in Korean patients with various neurological diseases.

Sun-Young Kim1, Jin-Hong Shin2, Jin-Sung Park3, Sa-Yoon Kang4, Tai-Seung Nam5, Jong Kuk Kim6, Ki-Jong Park7, So-Young Huh8, Ji Seon Oh9, Boram Kang2, Dae-Seong Kim10.   

Abstract

Azathioprine (AZA)-induced leukopenia is a relatively common complication in Korean patients. In addition to variation in TPMT (thiopurine S-methyltransferase), the NUDT15 p.R139C variant was recently identified to have a strong association with AZA-induced leukopenia. We investigated these associations in Korean patients undergoing AZA treatment with various neurological diseases. Among 84 enrolled patients, 20 (23.8%; 7 early, 13 late) exhibited leukopenia. The NUDT15 p.R139C variant was associated with leukopenia (OR: 11.844, 95% CI 3.984-36.024, p=1.327 × 10-5). The allelic frequency of NUDT15 p.R139C was as high as 10.7% and the frequency of the C/C, C/T, and T/T genotypes was 84.5, 10.7, and 5.9%, respectively. All T/T homozygous patients (5/5) developed early severe-grade leukopenia (white blood cells <1000mm-3) and severe alopecia. NUDT15 p.R139C was strongly associated with early leukopenia and severe alopecia (OR for early leukopenia: 107.624, 95% CI 18.857-614.250, p=1.403 × 10-7, OR for severe alopecia: 77.152, 95% CI 17.378-342.526, p=1.101 × 10-8). The sensitivity and specificity for predicting AZA-induced early leukopenia were 85.7% and 92.2%, respectively. Therefore, the NUDT15 p.R139C variant is common and strongly associated with AZA-induced early leukopenia and severe alopecia in Korean patients with various neurological diseases.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Azathioprine; Korea; Leukopenia; NUDT15; TPMT

Mesh:

Substances:

Year:  2017        PMID: 28566182     DOI: 10.1016/j.jns.2017.04.041

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

1.  Effects of various genetic polymorphisms on thiopurine treatment-associated outcomes for Korean patients with Crohn's disease.

Authors:  Rihwa Choi; Mi-Na Lee; Kyunga Kim; Sun-Young Baek; Tae Jun Kim; Sung Noh Hong; Young-Ho Kim; Soo-Youn Lee
Journal:  Br J Clin Pharmacol       Date:  2020-06-01       Impact factor: 4.335

2.  Associations between the NUDT15 R139C polymorphism and susceptibility to thiopurine-induced leukopenia in Asians: a meta-analysis.

Authors:  Yulan Liu; Yang Meng; Lu Wang; Zhou Liu; Jiao Li; Weiguo Dong
Journal:  Onco Targets Ther       Date:  2018-11-23       Impact factor: 4.147

Review 3.  Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases.

Authors:  Keiichi Tominaga; Takeshi Sugaya; Takanao Tanaka; Mimari Kanazawa; Makoto Iijima; Atsushi Irisawa
Journal:  Front Pharmacol       Date:  2021-01-29       Impact factor: 5.810

4.  Association Between Genetic Polymorphisms of Metabolic Enzymes and Azathioprine-Induced Myelosuppression in 1,419 Chinese Patients: A Retrospective Study.

Authors:  Zhao-Yang Chen; Yang-Hui Zhu; Ling-Yan Zhou; Wei-Qiao Shi; Zhou Qin; Bin Wu; Yu Yan; Yu-Wen Pei; Ning-Ning Chao; Rui Zhang; Mi-Ye Wang; Ze-Hao Su; Xiao-Jun Lu; Zhi-Yao He; Ting Xu
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.810

Review 5.  Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations.

Authors:  Kanyarat Khaeso; Sariya Udayachalerm; Patcharee Komvilaisak; Su-On Chainansamit; Kunanya Suwannaying; Napat Laoaroon; Pitchayanan Kuwatjanakul; Nontaya Nakkam; Chonlaphat Sukasem; Apichaya Puangpetch; Wichittra Tassaneeyakul; Nathorn Chaiyakunapruk
Journal:  Front Pharmacol       Date:  2021-12-02       Impact factor: 5.810

Review 6.  An Updated Review of Genetic Associations With Severe Adverse Drug Reactions: Translation and Implementation of Pharmacogenomic Testing in Clinical Practice.

Authors:  Chuang-Wei Wang; Ivan Arni C Preclaro; Wei-Hsiang Lin; Wen-Hung Chung
Journal:  Front Pharmacol       Date:  2022-04-25       Impact factor: 5.988

7.  NUDT15 R139C Variants Increase the Risk of Azathioprine-Induced Leukopenia in Chinese Autoimmune Patients.

Authors:  Xiang Fei; Qing Shu; Huaijun Zhu; Bingzhu Hua; Shiying Wang; Ling Guo; Yun Fang; Weihong Ge
Journal:  Front Pharmacol       Date:  2018-05-07       Impact factor: 5.810

8.  Optimal predictor for 6-mercaptopurine intolerance in Chinese children with acute lymphoblastic leukemia: NUDT15, TPMT, or ITPA genetic variants?

Authors:  Hong Zhou; Lei Li; Peng Yang; Lin Yang; Jin E Zheng; Ying Zhou; Yong Han
Journal:  BMC Cancer       Date:  2018-05-02       Impact factor: 4.430

9.  Association between the c.415C > T, c.52G > A, and 36_37insGGAGTC polymorphisms of NUDT 15 and thiopurine-induced leukopenia, thiopurine intolerance, and severe hair loss: an updated meta-analysis.

Authors:  Ruili Wang; Baogang Liu; Jiapeng Li; Jiamin Xu; Xiaoling Wang; Zhigang Zhao; Libo Zhao
Journal:  Drug Des Devel Ther       Date:  2019-08-05       Impact factor: 4.162

10.  Predictive Value of NUDT15 Variants on Neutropenia Among Han Chinese Patients with Dermatologic Diseases: A Single-Center Observational Study.

Authors:  Po-Wei Huang; Yu-Hsian Tseng; Tsen-Fang Tsai
Journal:  Dermatol Ther (Heidelb)       Date:  2020-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.